Chevy Chase Trust Holdings, Inc. Vertex Pharmaceuticals Inc Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 444,701 shares of VRTX stock, worth $216 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
444,701
Previous 446,861
0.48%
Holding current value
$216 Million
Previous $208 Million
13.83%
% of portfolio
0.55%
Previous 0.64%
Shares
31 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
222MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.7 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.3 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.81 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.06 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...